½ÃÀ庸°í¼­
»óǰÄÚµå
1650836

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º° - ºÐ¼®°ú ¿¹Ãø(2024-2033³â)

Asia-Pacific ENT Devices Market: Focus on Product Type, End User, and Country - Analysis and Forecast, 2024-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BIS Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 1-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 46¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù.

ÀÌ ½ÃÀåÀº 2024-2033³âÀÇ ¿¹Ãø ±â°£ Áß 6.72%ÀÇ CAGR·Î È®´ëÇϸç, 2033³â¿¡´Â 83¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Æ½Ã¾ÆÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå¿¡´Â ±Í, ÄÚ, ¸ñ(ENT) ÁúȯÀÇ ½Äº°, Ä¡·á, °ü¸®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ ÀÇ·á±â±â°¡ Æ÷ÇԵ˴ϴÙ. À̺ñÀÎÈİú ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÃÖ¼Ò Ä§½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϸ鼭 ÀÌ ½ÃÀåÀÇ ±Þ¼ÓÇÑ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Àΰø¿Í¿ì, ³»½Ã°æ ±â±â, º¸Ã»±â µîÀÇ ±â¼ú °³¹ßÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí À̺ñÀÎÈİú Àü¹®ÀÇÀÇ ±â¼úÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù.

À̺ñÀÎÈİú ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÓ»ó½ÃÇè ¹× Á¶»ç ¿¬±¸ Áõ°¡, ÃÖ÷´Ü À̺ñÀÎÈİú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù. ¶ÇÇÑ º¸´Ù Á¤±³Çϰí È¿°úÀûÀÎ Á¦Ç°ÀÇ °³¹ßÀº ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ »ç¿ëÀ¸·Î °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2024-2033³â
2024³âÀÇ Æò°¡¾× 46¾ï 4,000¸¸ ´Þ·¯
2033³â ¿¹Ãø 83¾ï 3,000¸¸ ´Þ·¯
CAGR 6.72%

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸¹Àº ±¹°¡¿¡¼­ Á¤ºÎÀÇ ±¸»ó°ú Àα¸ °í·ÉÈ­·Î ÀÎÇØ ½ÃÀå ±âȸ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À̺ñÀÎÈİú Àåºñ´Â ¼Ò¸ÅÁ¡, ÀÎÅÍ³Ý Ç÷§Æû µî ´Ù¾çÇÑ À¯Åë ä³ÎÀ» ÅëÇØ ³Î¸® º¸±ÞµÇ¾î ½ÃÀå Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ Áö¿ªÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À̺ñÀÎÈİú Àåºñ ½ÃÀåÀº ±Í, ÄÚ, ¸ñ(ENT) ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ º¸Ã»±â, Àΰø¿Í¿ì, ³»½Ã°æ Àåºñ´Â ÀÌ Áö¿ª Àüü¿¡¼­ ȯÀÚÀÇ ¿¹ÈÄ, Áø´Ü ¹× Ä¡·áÀÇ Á¤È®¼ºÀ» Å©°Ô Çâ»ó½ÃŰ´Â ±â¼ú ¹ßÀüÀÇ ÇÑ ¿¹¿¡ ºÒ°úÇÕ´Ï´Ù.

À̺ñÀÎÈİú Áúȯ, ƯÈ÷ ¼ö¸é¹«È£ÈíÁõ, ºÎºñµ¿¿°, ³­Ã»ÀÇ À¯º´·ü Áõ°¡, Àúħ½ÀÀû À̺ñÀÎÈİú ¼ö¼úÀÇ »ç¿ë µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀåÀÌ ´õ¿í ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼ÀÇ °á°ú·Î ´õ ºü¸£°í ȸº¹ÀÌ ºü¸£¸ç, ÀÓ»ó °á°ú°¡ °³¼±µÇ°í, ´õ Á¤±³Çϰí È¿°úÀûÀÎ Á¦Ç°ÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À̺ñÀÎÈİú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â Àα¸ °í·ÉÈ­¿Í ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°µéÀº ¼Ò¸ÅÁ¡ ¹× ÀÎÅÍ³Ý Ç÷§ÆûÀ» ÅëÇØ ´õ ³Î¸® º¸±ÞµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í, Áö¿ª Àüü ½ÃÀå È®´ë¸¦ ÃËÁøÇϸç, ´õ ¸¹Àº ¼ÒºñÀÚÃþÀ» È®º¸ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

°³¿ä

Á¦1Àå ½ÃÀå

  • ¾÷°è Àü¸Á
  • À̺ñÀÎÈİú ±â±â ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿ªÇÐ

Á¦2Àå Áö¿ª

  • Áö¿ªº° °³¿ä
  • ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦3Àå ½ÃÀå - °æÀï º¥Ä¡¸¶Å·°ú ±â¾÷ °³¿ä

  • °æÀï ±¸µµ
    • ÁÖ¿ä Àü·«°ú °³¹ß
    • ÆÄÆ®³Ê½Ê, Á¦ÈÞ, »ç¾÷ È®´ë
    • »õ·Î¿î ¼­ºñ½º
    • ÇÕº´°ú Àμö
    • ±ÔÁ¦ ¹× ¹ýÀû Ȱµ¿
  • ±â¾÷ °³¿ä
    • Cochlear Limited
    • Hoya Corporation
    • Olympus Corporation

Á¦4Àå Á¶»ç ¹æ¹ý

KSA 25.02.26

Introduction to Asia-Pacific ENT Devices Market

The Asia-Pacific ENT devices market was valued at $4.64 billion in 2023 and is expected to reach $8.33 billion by 2033, growing at a CAGR of 6.72% during the forecast period 2024-2033. The market for ENT devices in Asia includes a broad range of medical equipment used to identify, treat, and manage disorders of the ear, nose, and throat (ENT). The growing incidence of ENT disorders and the growing need for minimally invasive procedures are driving this market's rapid expansion. Technological developments in cochlear implants, endoscopic devices, and hearing aids are improving patient outcomes and expanding the skills of ENT specialists in the area.

The increasing prevalence of ENT disorders, the rise in clinical trials and research studies, and the growing need for cutting-edge ENT devices are some of the factors propelling the market's expansion. Furthermore, the development of more sophisticated and effective products is being accelerated by the use of minimally invasive procedures.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$4.64 Billion
2033 Forecast$8.33 Billion
CAGR6.72%

Growing market opportunities are also being greatly aided by government initiatives and the aging of the population in many APAC nations. Additionally, ENT devices are becoming more widely available through a variety of distribution channels, such as retail stores and internet platforms, which is improving market accessibility and spurring regional growth.

Market Introduction

The APAC ENT Devices Market is expanding rapidly, driven by the rising prevalence of ear, nose, and throat (ENT) disorders and the growing demand for minimally invasive procedures. Digital hearing aids, cochlear implants, and endoscopic devices are just a few examples of the technological advancements that are greatly enhancing patient outcomes, diagnosis, and treatment precision throughout the region.

The market is expanding more quickly due to factors like the rising prevalence of ENT disorders, especially sleep apnea, sinusitis, and hearing loss, as well as the use of minimally invasive ENT procedures. More sophisticated and effective products with quicker recovery times and improved clinical outcomes are being developed as a result of these trends.

The need for ENT devices in APAC is also being fueled by the aging population and rising healthcare spending on cutting-edge medical technologies. These products are becoming more widely available through retail locations and internet platforms, which is improving accessibility and promoting market expansion throughout the area, guaranteeing a wider consumer base.

Market Segmentation:

Segmentation 1: by Product Type

  • Diagnostic Devices
  • Surgical Devices
  • Hearing Aids
  • Visualization Devices
  • Consumables
  • Others

Segmentation 2: by End User (Surgical Devices)

  • Hospitals
  • Ambulatory Centers
  • ENT Specialty Clinics

Segmentation 3: by End User (Diagnostic Devices)

  • Hospitals
  • Ambulatory Centers
  • ENT Speciality Clinics
  • Others

Segmentation 4: by Country

  • China
  • Japan
  • India
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific ENT devices market has been segmented based on product type and end user. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific ENT devices market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the APAC ENT devices market analyzed and profiled in the study involve established players that offer various kinds of products and services.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Cochlear Limited
  • Hoya Corporation
  • Olympus Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Industry Outlook
    • 1.1.1 Trends: Current and Future Impact Assessment
      • 1.1.1.1 Miniaturization of Sensors and Components in Hearing Aids and Implants
      • 1.1.1.2 Increasing Product Approval by Regulatory Authorities Leading to Various New Offerings in the Market
    • 1.1.2 Patent Analysis
      • 1.1.2.1 Patent Filing Trend (by Country)
      • 1.1.2.2 Patent Filing Trend (by Year)
    • 1.1.3 Regulatory Landscape
    • 1.1.4 Supply Chain Analysis
    • 1.1.5 Ongoing Clinical Trial Studies
  • 1.2 Impact of COVID-19 on ENT Devices Market
  • 1.3 Market Dynamics
    • 1.3.1 Market Drivers
      • 1.3.1.1 Upsurge in Prevalence of Hearing Disorders
      • 1.3.1.2 Growing Geriatric Population Leading to Increased Demand for ENT Devices
      • 1.3.1.3 Growing Preference for Minimally Invasive Procedures in ENT Specialty
    • 1.3.2 Market Restraints
      • 1.3.2.1 High Cost of ENT Procedure
      • 1.3.2.2 Social Stigma Associated with Hearing Disorder
    • 1.3.3 Market Opportunities
      • 1.3.3.1 Increasing Demand for Cosmetic ENT Procedures

2 Region

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Factors Driving the Market Growth
    • 2.2.3 Factors Impeding/Limiting the Market Growth
    • 2.2.4 By Product Type
    • 2.2.5 By End User
    • 2.2.6 China
      • 2.2.6.1 By Product Type
      • 2.2.6.2 By End User
    • 2.2.7 Japan
      • 2.2.7.1 By Product Type
      • 2.2.7.2 By End User
    • 2.2.8 India
      • 2.2.8.1 By Product Type
      • 2.2.8.2 By End User
    • 2.2.9 Australia
      • 2.2.9.1 By Product Type
      • 2.2.9.2 By End User
    • 2.2.10 Rest-of-Asia-Pacific
      • 2.2.10.1 By Product Type
      • 2.2.10.2 By End User

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
    • 3.1.1 Key Strategies and Development
    • 3.1.2 Partnerships, Alliances, and Business Expansions
    • 3.1.3 New Offerings
    • 3.1.4 Mergers and Acquisitions
    • 3.1.5 Regulatory and Legal Activities
  • 3.2 Company Profiles
    • 3.2.1 Cochlear Limited
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers/End Users
      • 3.2.1.5 Analyst View
    • 3.2.2 Hoya Corporation
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products/Product Portfolio
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Target Customers/End Users
      • 3.2.2.5 Analyst View
    • 3.2.3 Olympus Corporation
      • 3.2.3.1 Overview
      • 3.2.3.2 Top Products/Product Portfolio
      • 3.2.3.3 Top Competitors
      • 3.2.3.4 Target Customers/End Users
      • 3.2.3.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦